|
|
Volumn 19, Issue 1, 2001, Pages 77-80
|
|
A phase II trial of pyrazoloacridine (PZA) in squamous carcinoma of the cervix: A gynecologic oncology group study
a
|
|
Author keywords
Cervical cancer; Pyrazoloacridine; PZA
|
|
Indexed keywords
2 (2 DIMETHYLAMINOETHYL) 9 METHOXY 5 NITROPYRAZOLO[3,4,5 KL]ACRIDINE;
ADULT;
ALOPECIA;
ANEMIA;
ARTICLE;
BLOOD TOXICITY;
BONE MARROW TOXICITY;
CANCER GROWTH;
CANCER RECURRENCE;
CANCER STAGING;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
GASTROINTESTINAL SYMPTOM;
HUMAN;
LEUKOPENIA;
LIVER DISEASE;
LUNG DISEASE;
NEUROLOGIC DISEASE;
NEUTROPENIA;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
SKIN DISEASE;
SQUAMOUS CELL CARCINOMA;
THROMBOCYTOPENIA;
TREATMENT OUTCOME;
UTERINE CERVIX CARCINOMA;
ACRIDINES;
ADULT;
AGED;
ANTINEOPLASTIC AGENTS;
CARCINOMA, SQUAMOUS CELL;
FEMALE;
HUMANS;
MIDDLE AGED;
PYRAZOLES;
TREATMENT OUTCOME;
UTERINE CERVICAL NEOPLASMS;
|
|
EID: 0035097064
PISSN: 01676997
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1006469006460 Document Type: Article |
|
Times cited : (9)
|
|
References (10)
|
